Beckman Coulter Expands Drugs of Abuse Test

Beckman Coulter, Inc. has expanded its drugs of abuse test menu to include a DRI* Oxycodone Enzyme Immunoassay (OXYX). The assay is for the qualitative and semi-quantitative determination of oxycodone and its metabolite, oxymorphone, in human urine.

Photo: Beckman Coulter Expands Drugs of Abuse Test

Reagents and calibrators for the DRI Oxycodone assay are liquid and ready-to-use, which eliminates the need for mixing, hydrating or pre-diluting reagents before testing. Drugs of Abuse Test (DAT) assays, available through Beckman Coulter, are specifically engineered, formulated and packaged to provide the critical elements of effective DAT analysis — speed, accuracy, ease-of-use and economy. When used in conjunction with Synchron® and UniCel® Clinical Chemistry Systems, these high quality assays provide timely, reliable and efficient DAT results.

About Oxycodone
Oxycodone is a semi-synthetic opioid prescribed for pain management in patients with moderate to severe pain. This narcotic pain reliever is similar to codeine and morphine in its analgesic properties, but is more potent than morphine and has greater potential for dependence. It is supplied as OxyContin* (Oxycodone HCI), or in combination with aspirin (Percodan*) or acetaminophen (Percocet*). The pills are often crushed into a powder and inhaled for a faster effect, which may result in a fatal outcome.

In addition to Oxycodone, Beckman Coulter’s broad DAT menu includes: amphetamines, barbiturates, barbiturates serum tox, benzodiazapine, benzodiazepine serum tox, cannabinoid, cocaine metabolite, ecstasy, methadone, methaqualone, opiates, phencyclidine, propoxyphene and tricyclics serum tox. Beckman Coulter also provides a wide range of test panels for anaemia, autoimmune conditions, cardiac disease, diabetes, therapeutic drug monitoring, general chemistry, hepatic function, infectious diseases, inflammatory proteins, lipids, nutritional assessment, renal function, thyroid function, toxicology, and specialty and STAT testing.

DRI Oxycodone Enzyme Immunoassay (OXYX) is a User Defined Reagent (UDR), manufactured by Thermo Fisher Scientific and distributed by Beckman Coulter, as part of its broad menu of automated chemistry assays.


Read all latest stories

Related articles


Sponsored • 100th DxA Automation System installed

Automation reimagines laboratory diagnostics service

San Paolo Hospital in Savona, Italy, has upgraded its Corelab-related analytical equipment. In collaboration with Beckman Coulter, the San Paolo diagnostic laboratory has installed Beckman…


Sponsored • Infection management

New sepsis marker speeds up detection and therapy

Sepsis is the cause of one in five deaths worldwide, killing nearly 11 million people each year, many of them children. It is also a major cause of disability, affecting millions more. To combat the…


Interview • Urinalysis for Covid-19 diagnostics

Automation to relieve pandemic pressure from laboratories

To provide a solution for the challenges of the coronavirus pandemic, Beckman Coulter recently launched the DxU Iris, a urinalysis solution which aims to improve lab workflows.

Related products

Access 2 Immunoassay System


Beckman Coulter · Access 2 Immunoassay System

Beckman Coulter Diagnostics
Access Procalcitonin (PCT)


Beckman Coulter · Access Procalcitonin (PCT)

Beckman Coulter Diagnostics
Antipsychotic Drug Monitoring

Clinical Chemistry

Beckman Coulter · Antipsychotic Drug Monitoring

Beckman Coulter Diagnostics
AU5800 Series

Clinical Chemistry

Beckman Coulter · AU5800 Series

Beckman Coulter Diagnostics
AutoMate 2500 Family Sample Processing Systems

Sample Processing

Beckman Coulter · AutoMate 2500 Family Sample Processing Systems

Beckman Coulter Diagnostics
Subscribe to Newsletter